Suppr超能文献

雷帕霉素五十周年纪念,仍是神奇药物:一种强效免疫抑制剂、抗肿瘤药、回春剂,以及COVID-19治疗中的潜在贡献者。

Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment.

作者信息

Mohamed Mohamed A, Elkhateeb Waill A, Daba Ghoson M

机构信息

Chemistry of Natural and Microbial Products Department, Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St. Dokki, Giza, 12622 Egypt.

出版信息

Bioresour Bioprocess. 2022;9(1):65. doi: 10.1186/s40643-022-00554-y. Epub 2022 Jun 13.

Abstract

Although celebrating its golden jubilee, rapamycin's importance keeps increasing by the day. Starting as a promising antifungal agent, then as a potent immunosuppressant, strong anticancer drug, and now rapamycin is attracting serious attention as a rejuvenative agent and a possible contributor in treating this era pandemic, COVID-19. Due to its diverse biological activities and promising medical applications, we aimed in this review to put rapamycin under the spot and highlight its discovery, famous microbial producers, reported biological activities, chemical structure, famous analogues, and biosynthesis. Moreover, discuss some rapamycin production approaches including solid-state fermentation, and stressing out producing strain. On the other hand, describe its action mechanism and trials to use it in treatment of COVID-19. Additionally, we highlighted some of the side effects accompanying its use, and describe some approaches reported to minimize these undesired effects. Finally, we report the current status of rapamycin and its analogues in global market, and discuss future prospects of this potent drug.

摘要

尽管雷帕霉素正在庆祝其五十周年纪念,但它的重要性与日俱增。雷帕霉素最初是一种有前景的抗真菌剂,后来成为一种强效免疫抑制剂、强力抗癌药物,现在它作为一种抗衰老剂以及在治疗当今大流行疾病 COVID-19 中可能发挥作用的药物,正吸引着人们的高度关注。由于其多样的生物活性和有前景的医学应用,我们在本综述中旨在聚焦雷帕霉素,突出其发现、著名的微生物生产者、已报道的生物活性、化学结构、著名类似物以及生物合成。此外,讨论一些雷帕霉素的生产方法,包括固态发酵,并着重介绍生产菌株。另一方面,描述其作用机制以及将其用于治疗 COVID-19 的试验情况。此外,我们强调了其使用过程中伴随的一些副作用,并描述了一些据报道可将这些不良影响降至最低的方法。最后,我们报告雷帕霉素及其类似物在全球市场的现状,并讨论这种强效药物的未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6351/10991802/4135ddd7da42/40643_2022_554_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验